SCHEMBL29655308

SCHEMBL29655308

C/C(=C\CO)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](OC(=O)Cc2ccc(O)c(O)c2)[C@H]1OC(=O)Cc1ccc(O)c(O)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 4/20 0.42
▸ CYP19A1 P11511 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ BACE1 P56817 2/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SLC5A1 P13866 1/20 0.37
▸ LGALS8 O00214 4/20 0.37
▸ SLC28A3 Q9HAS3 2/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ PPARG P37231 1/20 0.36
▸ PPARD Q03181 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ HRAS P01112 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29655349 0.96 SLC5A1 (0.41) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL29655360 0.96 SLC5A1 (0.41) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL29655306 0.90 LGALS8 (0.41) CYP3A4HSD17B10SLC5A1LGALS8SLC28A3
SCHEMBL29655356 0.89 PRKCA (0.38) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL29655336 0.86 PRKCA (0.42) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL28481755 0.73 PRKCA (0.70) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL17281059 0.66 PRKCA (0.67) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL17284917 0.66 PRKCA (0.67) PRKCACYP19A1L3MBTL1BACE1KDM1A
SCHEMBL15779695 0.64 PPARG (0.47) PRKCASLC5A1SLC28A3PPARGPPARD
SCHEMBL16119826 0.64 PPARG (0.47) PRKCASLC5A1SLC28A3PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 — — US disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 — — US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 — — EP disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 PRKCA 2722/4885CYP19A1 4650/4885L3MBTL1 4816/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 PRKCA 2722/4885CYP19A1 4650/4885L3MBTL1 4816/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 PRKCA 2722/4885CYP19A1 4650/4885L3MBTL1 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback